Personalized Medicine Centre, Almazov National Medical Research Centre, Saint Petersburg, Russian Federation.
Department of Laboratory Medicine and Genetics, Almazov National Medical Research Centre, Saint Petersburg, Russian Federation.
Int J Lab Hematol. 2024 Apr;46(2):336-344. doi: 10.1111/ijlh.14205. Epub 2023 Nov 20.
Establish the referenceintervals (RIs) and analyze biological variability (BV) to introduce the thrombin generation test (TGT) into clinical practice.
To determine the RIs parameters of TGT, we analyzed platelet-poor plasma (PPP) (n = 123), rich (PRP) (n = 76), and microparticle-mediated TGT (MP-TGT) (n = 32) in healthy participants. For the BV study, we collected samples from five participants over 5 weeks. A nested analysis of variance (ANOVA) was performed to evaluate the BV results.
The between-individual variation (CV ), within-individual variation (CV ), analytical variation (CV ) for TGT on PPP for all parameters were from 5.5% to 17.3%, 5.4% to 17.7%, and 2.6% to 5.3%, respectively. For PRP, the CV , CV , and CV were ranged from 3.0% to 23.7%, 8.4% to 23.0%, and 4.1% to 6.9%, respectively. The index of individuality (II) ranged from 0.3 to 3.1 for PPP and from 0.3 to 4.5 for PRP. The reference change value (RCV) for PPP was from 19.8% to 50.1%, while for PRP, it was 27.2% to 66.5%. We recommend using the RIs for the parameters ETP (nM/min): 1101.6-2332.1 and Peak (nM): 163.5-381.3 for PPP and ETP (nM/min): 1088.5-2634.9; Peak (nM): 72.6-210.7 for PRP. The resulting MP-TGT are highly dependent on age require a larger sample.
For TGT on PPP and PRP the RIs developed on our population for Peak and ETP parameters can be used. Time parameters: Lagtime and ttPeak, min with II < 0.6, require monitoring over time with RCV calculation.
建立参考区间(RIs)并分析生物学变异(BV),将凝血酶生成试验(TGT)引入临床实践。
为了确定 TGT 的 RIs 参数,我们分析了血小板贫乏血浆(PPP)(n=123)、富含血小板的血浆(PRP)(n=76)和微粒介导的 TGT(MP-TGT)(n=32)在健康参与者中的情况。为了进行 BV 研究,我们在 5 周内从 5 名参与者收集样本。采用嵌套方差分析(ANOVA)评估 BV 结果。
所有参数的 PPP 上 TGT 的个体间变异(CV )、个体内变异(CV )和分析变异(CV )分别为 5.5%至 17.3%、5.4%至 17.7%和 2.6%至 5.3%。对于 PRP,CV 、CV 和 CV 的范围分别为 3.0%至 23.7%、8.4%至 23.0%和 4.1%至 6.9%。PPP 的个体指数(II)范围为 0.3 至 3.1,PRP 的 II 范围为 0.3 至 4.5。PPP 的参考变化值(RCV)范围为 19.8%至 50.1%,PRP 的 RCV 范围为 27.2%至 66.5%。我们建议使用 PPP 参数 ETP(nM/min)的 RIs:1101.6-2332.1 和峰值(nM):163.5-381.3,以及 PRP 的 ETP(nM/min):1088.5-2634.9;峰值(nM):72.6-210.7。由此产生的 MP-TGT 高度依赖于年龄,需要更大的样本量。
对于 PPP 和 PRP 上的 TGT,我们人群中为峰值和 ETP 参数制定的 RIs 可以使用。时间参数:Lagtime 和 ttPeak,min 与 II<0.6,需要随着时间的推移通过 RCV 计算进行监测。